- Bruno S., Maisonneuve P., Castellana P., et al. Incidence and risk factors for non‐alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial. BMJ 2005; 330((7497))932
- Bauditz J., Schmidt H. H., Dippe P., Lochs H., Pirlich M. Non‐alcohol induced steatohepatitis in non‐obese patients: treatment with ursodeoxycholic acid. Am J Gastroenterol 2004; 99: 959–60
- Adams L. A., Angulo P. Vitamins E and C for the treatment of NASH: duplication of results but lack of demonstration of efficacy. Am J Gastroenterol 2003; 98: 2348–50
- Lavine J. E. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. J Pediatr 2000; 136: 734–8
- Szczepaniak L. S., Nurenberg P., Leonard D., et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005; 288: E462–8
- Ahmed M. H., Byrne C. D. Non‐alcoholic steatohepatitis. Metabolic Syndrome, C. D Byrne, S Wild. Wiley & Sons, London 2005; 279–303
- Murata Y., Ogawa Y., Saibara T., et al. Tamoxifen‐induced non‐alcoholic steatohepatitis in patients with breast cancer: determination of a suitable biopsy site for diagnosis. Oncol Rep 2003; 10: 97–100
- Ratziu V., Charlotte F., Heurtier A., et al. LIDO Study Group. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005; 128: 1898–906
- Choose new content alerts to be informed about new research of interest to you
- Easy remote access to your institution's subscriptions on any device, from any location
- Save your searches and schedule alerts to send you new results
- Export your search results into a .csv file to support your research